The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico

por Gómez-Álvarez, Enrique, Verdejo, Juan, Ocampo, Salvador, Ponte-Negretti, Carlos I., Ruíz, Emilio, Ríos, Marco Martínez
Publicado 2020